INVASIVE BREAST LOBULAR CARCINOMA

Clinical trials for INVASIVE BREAST LOBULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new INVASIVE BREAST LOBULAR CARCINOMA trials appear

Sign up with your email to follow new studies for INVASIVE BREAST LOBULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug attack on Hard-to-Treat breast cancer before surgery

Disease control Recruiting now

This study is testing if adding a drug called neratinib to standard hormone therapy before surgery helps treat a specific type of breast cancer. It is for people with stage I-III lobular breast cancer that has a specific genetic change (HER2 mutation). The goal is to see if this …

Matched conditions: INVASIVE BREAST LOBULAR CARCINOMA

Phase: PHASE2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control

Last updated Apr 02, 2026 00:41 UTC

INVASIVE BREAST LOBULAR CARCINOMA

Get alerted when new INVASIVE BREAST LOBULAR CARCINOMA trials appear

New drug attack on Hard-to-Treat breast cancer before surgery